Not all SCN1A epileptic encephalopathies are Dravet syndrome
Authors:
- Lynette G. SadleirLSLynette G. Sadleir
- Emily I. MountierEMEmily I. Mountier
- Deepak GillDGDeepak Gill
- Suzanne DavisSDSuzanne Davis
- Charuta JoshiCJCharuta Joshi
- Catherine DeVileCDCatherine DeVile
- Manju A. KurianMKManju A. Kurian
- For the DDD StudyFSFor the DDD Study
- Simone MandelstamSMSimone Mandelstam
- Elaine WirrellEWElaine Wirrell
- Katherine C. NickelsKNKatherine C. Nickels
- Hema R. MuraliHMHema R. Murali
Open Access
- 5 September 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 89 (10) , 1035-1042
Abstract
Objective: To define a distinct SCN1A developmental and epileptic encephalopathy with early onset, profound impairment, and movement disorder. Methods: A case series of 9 children were identified with a profound developmental and epileptic encephalopathy and SCN1A mutation. Results: We identified 9 children 3 to 12 years of age; 7 were male. Seizure onset was at 6 to 12 weeks with hemiclonic seizures, bilateral tonic-clonic seizures, or spasms. All children had profound developmental impairment and were nonverbal and nonambulatory, and 7 of 9 required a gastrostomy. A hyperkinetic movement disorder occurred in all and was characterized by dystonia and choreoathetosis with prominent oral dyskinesia and onset from 2 to 20 months of age. Eight had a recurrent missense SCN1A mutation, p.Thr226Met. The remaining child had the missense mutation p.Pro1345Ser. The mutation arose de novo in 8 of 9; for the remaining case, the mother was negative and the father was unavailable. Conclusions: Here, we present a phenotype-genotype correlation for SCN1A. We describe a distinct SCN1A phenotype, early infantile SCN1A encephalopathy, which is readily distinguishable from the well-recognized entities of Dravet syndrome and genetic epilepsy with febrile seizures plus. This disorder has an earlier age at onset, profound developmental impairment, and a distinctive hyperkinetic movement disorder, setting it apart from Dravet syndrome. Remarkably, 8 of 9 children had the recurrent missense mutation p.Thr226Met.Keywords
This publication has 18 references indexed in Scilit:
- High prevalence of genetic alterations in early-onset epileptic encephalopathies associated with infantile movement disordersBrain and Development, 2016
- SCN2A encephalopathyNeurology, 2015
- A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsyNature Genetics, 2014
- Dravet syndrome—From epileptic encephalopathy to channelopathyEpilepsia, 2014
- Sleep Abnormalities in Children With Dravet SyndromePediatric Neurology, 2014
- Role of the sodium channel SCN9A in genetic epilepsy with febrile seizures plus and Dravet syndromeEpilepsia, 2013
- The core Dravet syndrome phenotypeEpilepsia, 2011
- The spectrum of SCN1A-related infantile epileptic encephalopathiesBrain, 2007
- De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of InfancyThe American Journal of Human Genetics, 2001
- Neuronal Sodium-Channel α1-Subunit Mutations in Generalized Epilepsy with Febrile Seizures PlusThe American Journal of Human Genetics, 2001